Such are the alterations in BRAF, epidermal growth factor receptor (EGFR) gene, anaplastic lymphoma kinase (ALK) gene, Kirsten Rat Sarcoma virus (KRAS), repressor of silencing 1 (ROS-1) and PD-L1 for squamous cell carcinoma. This evidence concerns the gene ALK and squamous cell carcinoma.